文献速递眼底病与葡萄膜炎

大型医疗网络内糖尿病视网膜病变的纵向趋势与差异

Longitudinal Trends and Disparities in Diabetic Retinopathy Within an Aggregate Health Care Network.
PubMed 文献 · JAMA Ophthalmol · 2024-01-01

该横断面流行病学研究利用美国TriNetX网络56家医疗机构的去标识数据,纳入2015年至2022年359126例1型或2型糖尿病视网膜病变(T1DR/T2DR)患者,分析患病率趋势。结果显示T1DR和T2DR患病率均上升,20-39岁人群增幅最大,西班牙裔和黑人群体T2DR患病比值比更高。

要点

  • 2015至2022年T1DR患病率增加1.15倍,2022年达每10万人70.4例;T2DR增加1.07倍,达461.7例。
  • T1DR中20-39岁队列增幅最大达4.7倍和1.96倍;T2DR同年龄段增幅为2.5倍和1.6倍。
  • T2DR患病比值比:西班牙裔男性4.08(95%CI 3.97-4.19),西班牙裔女性2.49(2.42-2.56),黑人男性2.23(2.17-2.29),黑人女性2.00(1.95-2.05),均以白人女性为参照。

核心结论

  • 2015至2022年该网络内T1DR和T2DR患病率均上升,20-39岁人群增幅显著。
  • T2DR在西班牙裔和黑人社区中增幅更大。
  • 作者认为这些发现支持对年轻成人进行DR筛查,并针对受疾病影响最大的种族和族裔少数群体设计T2DR干预措施。
  • 作者指出未来需进一步研究年轻成人中的这些趋势。

研究设计与样本

  • 横断面流行病学评价,使用美国TriNetX Analytics健康研究网络56家医疗机构的去标识数据。
  • 纳入2015年1月1日至2022年12月21日期间具有T1DR或T2DR的ICD-10编码的患者,共359126例(平均[SD]年龄67[14]岁,52%女性)。
  • 按年龄组(20-29、30-39、40-49、50-59、60-69、70岁及以上)、种族和族裔、性别分层。

主要发现

  • T1DR患病率从2015至2022年增加1.15倍,2022年影响每10万人70.4例。
  • T2DR患病率增加1.07倍,2022年影响每10万人461.7例。
  • T1DR中20-39岁队列增幅最大,分别为4.7倍和1.96倍。
  • T2DR中20-39岁患者从2015至2022年患病率增加2.5倍和1.6倍。
  • T1DR中白人男性患病比值比最大,为1.41(95%CI 1.36-1.47),参照组为白人女性。

关键数值与推荐

  • T1DR患病比值比:白人男性1.41(95%CI 1.36-1.47),参照组白人女性。
  • T2DR患病比值比:西班牙裔男性4.08(95%CI 3.97-4.19),西班牙裔女性2.49(95%CI 2.42-2.56),黑人男性2.23(95%CI 2.17-2.29),黑人女性2.00(95%CI 1.95-2.05),参照组白人女性。

临床怎么用

  • 作者认为这些发现支持在年轻成人中进行DR筛查。
  • 作者认为这些发现支持针对受疾病影响最大的种族和族裔少数群体设计T2DR干预措施。

局限性

  • 作者指出未来需进一步研究以探究年轻成人中的这些趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Diabetic retinopathy (DR) is a leading cause of blindness in the US, warranting updates on its prevalence and incidence in the setting of advancements in diabetic care over recent years. OBJECTIVE: To determine recent trends in DR prevalence stratified by baseline demographics to identify those populations at greater risk. DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional epidemiologic evaluation conducted using deidentified data from the large federated TriNetX Analytics health research network composed of 56 health care organizations in the US. Patients from 2015 to 2022 who had an International Statistical Classification of Diseases and Related Health Problems, Tenth Revision code of type 1 DR (T1DR) or type 2 DR (T2DR) were included in this analysis. Patients were further stratified by age cohorts (20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, and 70 years or older), race and ethnicity, and sex. MAIN OUTCOMES AND MEASURES: Prevalence per 100 000 patients and prevalence odds ratios (ORs) were calculated in Microsoft Excel and Posit (formerly RStudio). RESULTS: A total of 359 126 patients with T1DR or T2DR (mean [SD] age, 67 [14] years; 52% female) were included in this study between January 1, 2015, and December 21, 2022. T1DR increased in prevalence from 2015 to 2022, with T1DR increasing 1.15-fold affecting 70.4 patients per 100 000 in 2022. T2DR increased 1.07-fold affecting 461.7 patients per 100 000 in 2022. For T1DR, the cohort aged 20 to 39 years had the most substantial increase at 4.7 and 1.96 fold. Overall, White males had the largest prevalence ORs of T1DR at 1.41 (95% CI, 1.36-1.47) compared with White females (reference group). In T2DR, patients aged 20 to 39 years again had a 2.5- and 1.6-fold prevalence increase from 2015 to 2022. Regardless of age group, Hispanic males demonstrated larger prevalence OR at 4.08 (95% CI, 3.97-4.19) compared with White females followed by Hispanic females at 2.49 (95% CI, 2.42-2.56), Black males at 2.23 (95% CI, 2.17-2.29), and Black females at 2.00 (95% CI, 1.95-2.05). CONCLUSION AND RELEVANCE: The prevalence of both T1DR and T2DR increased in this network from 2015 to 2022, with individuals aged 20 to 39 years showing large increases. Additionally, T2DR was associated with greater increases in both Hispanic and Black communities. These findings support DR screening in young adults and for T2DR interventions specifically designed for racial and ethnic minoritized patients most affected by disease. Future investigations are warranted to further investigate these trends among young adults.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Markle J, Shaia JK, Araich H, et al. Longitudinal Trends and Disparities in Diabetic Retinopathy Within an Aggregate Health Care Network. JAMA Ophthalmol. 2024. PMID: 38869883. doi:10.1001/jamaophthalmol.2024.0046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。